Brendan P. Eckelman - Apr 5, 2022 Form 4 Insider Report for Inhibrx, Inc. (INBX)

Role
Chief Scientific Officer
Signature
/s/ Kelly D. Deck, attorney-in-fact
Stock symbol
INBX
Transactions as of
Apr 5, 2022
Transactions value $
-$10,016
Form type
4
Date filed
4/7/2022, 04:11 PM
Next filing
Jul 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INBX Common Stock Sale -$10K -400 -0.02% $25.04 2.56M Apr 5, 2022 By the Eckelman Living Trust dated February 5, 2014 F1, F2, F3
holding INBX Common Stock 80K Apr 5, 2022 By trust F4
holding INBX Common Stock 80K Apr 5, 2022 By trust F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Eckelman Living Trust on October 28, 2021.
F2 The shares were sold in multiple transactions at prices ranging from $25.00 to $25.08, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3 These securities are directly owned by the Eckelman Living Trust dated February 5, 2014. Brendan P. Eckelman is the trustee of the Eckelman Living Trust dated February 5, 2014 and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the Eckelman Living Trust dated February 5, 2014.
F4 These securities are directly owned by a trust, for the benefit of Brendan P. Eckelman's minor son. Brendan P. Eckelman is the trustee of the trust, and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the trust.
F5 These securities are directly owned by a trust, for the benefit of Brendan P. Eckelman's minor daughter. Brendan P. Eckelman is the trustee of the trust, and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the trust.